Personal. Advanced. Proactive: Our plan for cancer care
We are pleased to share the 2016 Sentara Cancer Network Annual Report. It has truly been a remarkable year in clinical advances within oncology across the country. One year ago, the White House announced the national Cancer Moonshot program to accelerate progress against cancer. This shared vision of progress has reinvigorated the research community, identified new areas of scientific collaboration, and raised our ambitions regarding what may be possible beyond the progress we have already made in the treatment of cancer. The advances highlighted in this report attest to a key trend that is driving progress against cancer today in regards to Precision Therapy. Cancer therapies are becoming increasingly precise, thereby enabling a more personalized approach to treatment selection. The research into cancer biology is propelling rapid development with many new novel treatments in the pipeline for approval by the FDA.
Thanks to earlier detection, advanced treatment and supportive care, more Americans are surviving cancer than ever before. In fact, there are almost 14.5 million cancer survivors alive in the United States today, and that number is expected to grow to nearly 19 million by 2024 as reported by the American Cancer Society. Due to all of these efforts, many cancers can now be regarded as more chronic in nature. While we have made great strides forward, we realize that the same therapies that were used to treat the disease create their own challenges in the medical community. Addressing the needs of cancer survivors has been a focused area for the Sentara Cancer Network this year as we continue to work with our cancer survivors and their families to ensure we have the right services and programs in place to not only meet their needs but to help them fully embrace their survivorship. Throughout the report, you will see the commitment that the Sentara Cancer Network has on improving the health of our community. Our physicians, nurses and staff participate in many prevention, education and screening programs to raise the awareness for cancer support and improve the overall health of our communities.
As the only designated Integrated Cancer Program in Virginia, by the American College of Surgeons Commission on Cancer, we are in a position to provide expert care close to home. Through our multidisciplinary team approach, evidence-based protocols, cutting-edge technologies and advanced clinical trials, patients can rest assured that they are receiving quality care throughout our entire Sentara Cancer Network. This 2016-17 Annual Report summarizes many of our accomplishments including:
- Adding new diagnostic and treatment technologies to our arsenal of cancer-fighting tools as they become available
- Welcoming outstanding new physicians and staff to our team
- Listening to what our patients are telling us, and focusing on access
and refining processes to improve our patients’ experiences
- Creating innovative new programs, such as our next generation
molecular lab capacities
- Survivorship Program, to enhance our patients’ well-being and
- Increasing our clinical research activity and expanded clinical
- Creating a safe environment for care delivery
- Providing our community with cancer screening services and cancer prevention education.
As we reflect on the outstanding accomplishments for this year, and for the excitement that is ahead with the transformation in oncology care, we are privileged to share these accomplishments, as well as many more highlighted throughout this report.
Richard A. Hoefer, D.O., FACS
Sentara Cancer Network
Thomas A. Alberico, M.D.
Chair, Oncology High Performance Team
James Schneider, M.D., FACS
Cancer Liaison Physician (CLP), Sentara Cancer Network
Vice President, Sentara Cancer Network